Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-Pen vs Lilly Glucagon for Hypoglycemia Rescue in T1D
NCT03439072Phase 3Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Jan 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of G-Pen in hypoglycemia, sponsored by Xeris Biopharma Holdings, Inc.. Started Jan 2018; status: completed.
02
Drugs
G-Pen
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT03439072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03439072.